Inactive Instrument

Luminex Corporation

Equities

LMNX

US55027E1029

Advanced Medical Equipment & Technology

Luminex Corporation Revises Revenue Guidance for the Year 2021

January 12, 2021 at 06:00 am EST

Luminex Corporation revised revenue guidance for the year 2021. The company is raising its previously provided 2021 revenue guidance to reflect that the company currently expects 2021 revenue to be approximately $480 million, which would represent a 15% increase from 2020 full-year revenue.

Latest news about Luminex Corporation

Cytek Biosciences, Inc. completed the acquisition of Flow Cytometry & Imaging business unit of Luminex Corporation for $44.9 million.	23-02-27	CI
Transcript : Cytek Biosciences, Inc., Luminex Corporation - M&A Call	23-02-13
Cytek Biosciences, Inc. entered into an agreement to acquire Flow Cytometry & Imaging business unit of Luminex Corporation for $46.5 million.	23-02-12	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600 Health Care	21-07-15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 1000	21-07-15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P TMI Index	21-07-15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Global BMI Index	21-07-15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P Composite 1500	21-07-15	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from S&P 600	21-07-15	CI
Luminex Corporation Announces Executive Changes	21-07-14	CI
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Composite Index	21-07-14	CI
DiaSorin S.p.A. completed the acquisition of Luminex Corporation from BlackRock, Inc., Biomedical Advanced Research And Development Authority, The Vanguard Group, Inc., RGM Capital, LLC and others.	21-07-13	CI
Update: Middlesex Water to Replace Luminex in S&P SmallCap 600 -- Shares Jump in Pre-Market Trading	21-07-13	MT
Middlesex Water : to Replace Luminex in S&P SmallCap 600	21-07-13	MT
Luminex Corporation(NasdaqGS:LMNX) dropped from NASDAQ Biotechnology Index	21-07-13	CI
Middlesex Water : S&P Dow Jones Indices Says Middlesex Water Company (MSEX) to Replace Luminex (LMNX) in S&P SmallCap 600 from July 15	21-07-12	MT
Luminex : Gets US Regulatory Approval for Acquisition by DiaSorin	21-07-09	MT
Luminex : Quarterly Dividend Unchanged at $0.10 Per Share, Payable July 8 to Stockholders of Record on June 17	21-05-20	MT
Luminex Corporation Declared Cash Dividend for the Second Quarter of 2021, Payable on July 8, 2021	21-05-20	CI
Luminex Corporation Reports Earnings Results for the First Quarter Ended March 31, 2021	21-05-05	CI
LUMINEX : Piper Sandler Downgrades Luminex to Neutral From Overweight; Price Target is $37	21-04-13	MT
LUMINEX : BTIG Downgrades Luminex to Neutral From Buy	21-04-13	MT
Sector Update: Health Care Stocks Slip as Midday Gains Evaporate	21-04-12	MT
Sector Update: Health Care Stocks Drifting Higher This Afternoon	21-04-12	MT
Sector Update: Health Care	21-04-12	MT

Chart Luminex Corporation

Duration

Period

More charts

Company Profile

Luminex Corporation is a United States-based company that is a biotechnology company. The Company is involved in developing, manufacturing and marketing biological testing technologies in the clinical diagnostic and life science industries. Its offer a solution applicable in the markets, including clinical diagnostics, pharmaceutical drug discovery, genomic and proteomic research, biomedical research and food safety.

Sector

Advanced Medical Equipment & Technology

More about the company

Sector Other Advanced Medical Equipment & Technology

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+12.06%	225B
DANAHER CORPORATION	+12.07%	186B
INTUITIVE SURGICAL, INC.	+13.88%	135B
BOSTON SCIENTIFIC CORPORATION	+27.12%	107B
SIEMENS HEALTHINEERS AG	+0.91%	63.56B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+6.74%	51.32B
EDWARDS LIFESCIENCES CORPORATION	+13.39%	51.04B
AGILENT TECHNOLOGIES, INC.	+8.81%	43.3B
GE HEALTHCARE TECHNOLOGIES INC.	+4.14%	36.99B

Other Advanced Medical Equipment & Technology